Effect of a Single Nights' Wake Followed by Bright Light Therapy for Severe Depression
- Conditions
- Depression
- Interventions
- Behavioral: Single night's wake therapyOther: Treatment as usual - inpatient careDevice: Bright lightOther: Informative meetingDrug: Treatment as usual - medicine
- Registration Number
- NCT02503124
- Lead Sponsor
- Sahlgrenska University Hospital, Sweden
- Brief Summary
A randomized controlled trial comparing wake therapy (single night) followed by bright light therapy to treatment as usual.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 32
- Depressive episode requiring admission to a psychiatric hospital (including unipolar and bipolar depression).
- Psychotic symptoms/agitation
- Compulsory admission
- Confusion
- Active substance use disorder
- Eye disease preventing bright light therapy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Chronobiological intervention Bright light Single night's wake therapy followed by bright light therapy for a week as add-on treatment to treatment as usual. Chronobiological intervention Single night's wake therapy Single night's wake therapy followed by bright light therapy for a week as add-on treatment to treatment as usual. Control Treatment as usual - inpatient care Treatment as usual including a private educational meeting in sleep hygiene. Control Treatment as usual - medicine Treatment as usual including a private educational meeting in sleep hygiene. Chronobiological intervention Treatment as usual - inpatient care Single night's wake therapy followed by bright light therapy for a week as add-on treatment to treatment as usual. Chronobiological intervention Treatment as usual - medicine Single night's wake therapy followed by bright light therapy for a week as add-on treatment to treatment as usual. Control Informative meeting Treatment as usual including a private educational meeting in sleep hygiene.
- Primary Outcome Measures
Name Time Method MADRS-S score reduction of 50% One week Montgomery Asberg Depression Rating Scale
- Secondary Outcome Measures
Name Time Method MADRS-S score at discharge Participants will be followed at discharge, an expected average of 2-3 weeks Montgomery Asberg Depression Rating Scale
MADRS-S score at follow-up 10-14 weeks Montgomery Asberg Depression Rating Scale
ISI score score at discharge Participants will be followed at discharge, an expected average of 2-3 weeks Insomnia Severity Index - Self administered scale of sleep quality
ISI score score at follow-up 10-14 weeks Insomnia Severity Index - Self administered scale of sleep quality
ISI score reduction of 50% One week Insomnia Severity Index - Self administered scale of sleep quality
Length of stay The number of days between admission and discharge Patients will be followed up 10-14 weeks after discharge and the total number of days in inpatient services calculated.
Re-admission 10-14 weeks CGI score 10-14 weeks Clinical global impression
Medication use 10-14 weeks The use of antidepressants, anxiolytics or other psychiatric medication will be registered at follow-up. The number of patients using more than one medication and the dosage will be compared.
Trial Locations
- Locations (1)
Sahlgrenska University Hospital
🇸🇪Gothenburg, Västra Götaland, Sweden